Column GROUP III Gp, L.P., 10% Owner at Tenaya Therapeutics, Inc. (TNYA), sold 4,170,266 shares at $0.62 ($2.4M) on 2026-02-24, disclosed to the SEC on 2026-02-26.
Open-market sale of $2.4M TNYA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.62 | 309,228 | $190K | 8.0% |
| 2 | $0.62 | 349,212 | $215K | 9.0% |
| 3 | $0.56 | 1,649,281 | $928K | 39.0% |
| 4 | $0.56 | 1,862,545 | $1.0M | 44.0% |
| Total | $0.57 avg | 4,170,266 | $2.4M | 100% |
| Filing → |
| SRZN | BUY | 2026-01-20 | $642K | — | Filing → |
| SRZN | BUY | 2026-01-08 | $300K | — | Filing → |
| SRZN | BUY | 2025-12-08 | $1.3M | — | Filing → |